APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Humanized Collagen

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Humanized Collagen Industry Growth and Trends Forecast to 2032

23 December 202596 pages

Choose your research edition.

Industry ResearchRecombinant Humanized Collagen Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Humanized Collagen Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Recombinant Humanized Collagen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Humanized Collagen Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Humanized Collagen Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Recombinant Humanized Collagen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Humanized Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Humanized Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Humanized Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Humanized Collagen include Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology, ProColl, Evonik, Creative BioMart and CollPlant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Humanized Collagen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Humanized Collagen market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Humanized Collagen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Humanized Collagen.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Humanized Collagen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Humanized Collagen Market by Company

Giant Biogene

Shanxi Jinbo Bio-Pharmaceutical

Jiangsu JLand Biotech

Jiangsu Chuangjian Medical Technology

ProColl

Evonik

Creative BioMart

CollPlant

Recombinant Humanized Collagen Segment by Type

Type A

Type B

Recombinant Humanized Collagen Segment by Application

Cosmetics

Biotechnology

Medicine

Other

Recombinant Humanized Collagen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Humanized Collagen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Humanized Collagen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Humanized Collagen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Humanized Collagen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Humanized Collagen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Type A Table 2. Major Company of Type B Table 3. Global Recombinant Humanized Collagen Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 5. Global Recombinant Humanized Collagen Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Humanized Collagen Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Humanized Collagen Price by Type (2021-2026) & (USD/kg) Table 9. Global Recombinant Humanized Collagen Sales by Type (2027-2032) & (t) Table 10. Global Recombinant Humanized Collagen Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Humanized Collagen Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Humanized Collagen Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Humanized Collagen Price by Type (2027-2032) & (USD/kg) Table 14. North America Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 15. North America Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 17. Europe Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 21. Latin America Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Humanized Collagen Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Recombinant Humanized Collagen Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Humanized Collagen Industry Trends Table 25. Recombinant Humanized Collagen Industry Drivers Table 26. Recombinant Humanized Collagen Industry Opportunities and Challenges Table 27. Recombinant Humanized Collagen Industry Restraints Table 28. Global Recombinant Humanized Collagen Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Humanized Collagen Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Humanized Collagen Sales by Company (2021-2026) & (t) Table 31. Global Recombinant Humanized Collagen Sales Share by Company (2021-2026) Table 32. Global Recombinant Humanized Collagen Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Recombinant Humanized Collagen Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Humanized Collagen Major Company Production Sites and Headquarters Table 35. Global Recombinant Humanized Collagen Company, Product Type & Application Table 36. Global Recombinant Humanized Collagen Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Humanized Collagen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Humanized Collagen Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Humanized Collagen Sales by Region (2021-2026) & (t) Table 41. Global Recombinant Humanized Collagen Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Humanized Collagen Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Humanized Collagen Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Humanized Collagen Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Recombinant Humanized Collagen Sales by Region (2027-2032) & (t) Table 46. Global Recombinant Humanized Collagen Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Humanized Collagen Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Humanized Collagen Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Humanized Collagen Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Recombinant Humanized Collagen Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 52. Global Recombinant Humanized Collagen Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Humanized Collagen Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Humanized Collagen Price by Application (2021-2026) & (USD/kg) Table 56. Global Recombinant Humanized Collagen Sales by Application (2027-2032) & (t) Table 57. Global Recombinant Humanized Collagen Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Humanized Collagen Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Humanized Collagen Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Humanized Collagen Price by Application (2027-2032) & (USD/kg) Table 61. North America Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 62. North America Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 64. Europe Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 68. Latin America Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Humanized Collagen Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Recombinant Humanized Collagen Sales by Application (2021-2026) & (US$ Million) Table 71. Giant Biogene Company Information Table 72. Giant Biogene Business Overview Table 73. Giant Biogene Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Giant Biogene Recombinant Humanized Collagen Product Portfolio Table 75. Giant Biogene Recent Development Table 76. Shanxi Jinbo Bio-Pharmaceutical Company Information Table 77. Shanxi Jinbo Bio-Pharmaceutical Business Overview Table 78. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolio Table 80. Shanxi Jinbo Bio-Pharmaceutical Recent Development Table 81. Jiangsu JLand Biotech Company Information Table 82. Jiangsu JLand Biotech Business Overview Table 83. Jiangsu JLand Biotech Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolio Table 85. Jiangsu JLand Biotech Recent Development Table 86. Jiangsu Chuangjian Medical Technology Company Information Table 87. Jiangsu Chuangjian Medical Technology Business Overview Table 88. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolio Table 90. Jiangsu Chuangjian Medical Technology Recent Development Table 91. ProColl Company Information Table 92. ProColl Business Overview Table 93. ProColl Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. ProColl Recombinant Humanized Collagen Product Portfolio Table 95. ProColl Recent Development Table 96. Evonik Company Information Table 97. Evonik Business Overview Table 98. Evonik Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Evonik Recombinant Humanized Collagen Product Portfolio Table 100. Evonik Recent Development Table 101. Creative BioMart Company Information Table 102. Creative BioMart Business Overview Table 103. Creative BioMart Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Creative BioMart Recombinant Humanized Collagen Product Portfolio Table 105. Creative BioMart Recent Development Table 106. CollPlant Company Information Table 107. CollPlant Business Overview Table 108. CollPlant Recombinant Humanized Collagen Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. CollPlant Recombinant Humanized Collagen Product Portfolio Table 110. CollPlant Recent Development Table 111. North America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 112. North America Recombinant Humanized Collagen Sales by Country (2021-2026) & (t) Table 113. North America Recombinant Humanized Collagen Sales Market Share by Country (2021-2026) Table 114. North America Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (t) Table 115. North America Recombinant Humanized Collagen Sales Market Share Forecast by Country (2027-2032) Table 116. North America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Recombinant Humanized Collagen Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Recombinant Humanized Collagen Market Share by Country (2021-2026) Table 119. North America Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Recombinant Humanized Collagen Market Share Forecast by Country (2027-2032) Table 121. Europe Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 122. Europe Recombinant Humanized Collagen Sales by Country (2021-2026) & (t) Table 123. Europe Recombinant Humanized Collagen Sales Market Share by Country (2021-2026) Table 124. Europe Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (t) Table 125. Europe Recombinant Humanized Collagen Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Recombinant Humanized Collagen Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Recombinant Humanized Collagen Market Share by Country (2021-2026) Table 129. Europe Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Recombinant Humanized Collagen Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Recombinant Humanized Collagen Sales by Country (2021-2026) & (t) Table 133. Asia-Pacific Recombinant Humanized Collagen Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (t) Table 135. Asia-Pacific Recombinant Humanized Collagen Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Recombinant Humanized Collagen Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Recombinant Humanized Collagen Market Share by Country (2021-2026) Table 139. Asia-Pacific Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Recombinant Humanized Collagen Market Share Forecast by Country (2027-2032) Table 141. Latin America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 142. Latin America Recombinant Humanized Collagen Sales by Country (2021-2026) & (t) Table 143. Latin America Recombinant Humanized Collagen Sales Market Share by Country (2021-2026) Table 144. Latin America Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (t) Table 145. Latin America Recombinant Humanized Collagen Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Recombinant Humanized Collagen Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Recombinant Humanized Collagen Market Share by Country (2021-2026) Table 149. Latin America Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Recombinant Humanized Collagen Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Recombinant Humanized Collagen Sales by Country (2021-2026) & (t) Table 153. Middle East and Africa Recombinant Humanized Collagen Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (t) Table 155. Middle East and Africa Recombinant Humanized Collagen Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Recombinant Humanized Collagen Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Recombinant Humanized Collagen Market Share by Country (2021-2026) Table 159. Middle East and Africa Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Recombinant Humanized Collagen Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Recombinant Humanized Collagen Distributors List Table 164. Recombinant Humanized Collagen Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Recombinant Humanized Collagen Image Figure 2. Global Recombinant Humanized Collagen Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Humanized Collagen Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Humanized Collagen Sales (2021-2032) & (t) Figure 5. Type A Image Figure 6. Global Type A Sales YoY Growth (2021-2032) & (t) Figure 7. Type B Image Figure 8. Global Type B Sales YoY Growth (2021-2032) & (t) Figure 9. Global Recombinant Humanized Collagen Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Humanized Collagen Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Humanized Collagen Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Humanized Collagen Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Humanized Collagen Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Humanized Collagen Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Humanized Collagen Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Humanized Collagen Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Humanized Collagen Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Humanized Collagen Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Humanized Collagen Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Humanized Collagen Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Humanized Collagen Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cosmetics Image Figure 24. Global Cosmetics Sales YoY Growth (2021-2032) & (t) Figure 25. Biotechnology Image Figure 26. Global Biotechnology Sales YoY Growth (2021-2032) & (t) Figure 27. Medicine Image Figure 28. Global Medicine Sales YoY Growth (2021-2032) & (t) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (t) Figure 31. Global Recombinant Humanized Collagen Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant Humanized Collagen Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant Humanized Collagen Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant Humanized Collagen Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant Humanized Collagen Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant Humanized Collagen Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant Humanized Collagen Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant Humanized Collagen Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant Humanized Collagen Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant Humanized Collagen Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant Humanized Collagen Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant Humanized Collagen Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant Humanized Collagen Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Recombinant Humanized Collagen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant Humanized Collagen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant Humanized Collagen Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Humanized Collagen Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Recombinant Humanized Collagen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Humanized Collagen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant Humanized Collagen Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Humanized Collagen Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Recombinant Humanized Collagen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Humanized Collagen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant Humanized Collagen Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Humanized Collagen Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Recombinant Humanized Collagen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Humanized Collagen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant Humanized Collagen Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Humanized Collagen Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Recombinant Humanized Collagen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Humanized Collagen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant Humanized Collagen Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant Humanized Collagen Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Humanized Collagen Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Type A
  • Type B
Applications
  • Cosmetics
  • Biotechnology
  • Medicine
  • Other
Companies covered
  • Giant Biogene
  • Shanxi Jinbo Bio-Pharmaceutical
  • Jiangsu JLand Biotech
  • Jiangsu Chuangjian Medical Technology
  • ProColl
  • Evonik
  • Creative BioMart
  • CollPlant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Humanized Collagen Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Humanized Collagen Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Humanized Collagen Market by Type
  6. 1.3.1 Type A
  7. 1.3.2 Type B
  8. 1.4 Global Recombinant Humanized Collagen Market Size by Type
  9. 1.4.1 Global Recombinant Humanized Collagen Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Humanized Collagen Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Humanized Collagen Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Humanized Collagen Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Humanized Collagen Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Humanized Collagen Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Humanized Collagen Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Humanized Collagen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Humanized Collagen Industry Trends
  2. 2.2 Recombinant Humanized Collagen Industry Drivers
  3. 2.3 Recombinant Humanized Collagen Industry Opportunities and Challenges
  4. 2.4 Recombinant Humanized Collagen Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Humanized Collagen Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Humanized Collagen Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Humanized Collagen Price (2021-2026)
  4. 3.4 Global Recombinant Humanized Collagen Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Humanized Collagen Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Humanized Collagen Company, Product Type & Application
  7. 3.7 Global Recombinant Humanized Collagen Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Humanized Collagen Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Humanized Collagen Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Humanized Collagen Tier 1, Tier 2, and Tier 3
4 Recombinant Humanized Collagen Regional Status and Outlook
  1. 4.1 Global Recombinant Humanized Collagen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Humanized Collagen Historic Market Size by Region
  3. 4.2.1 Global Recombinant Humanized Collagen Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Humanized Collagen Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Humanized Collagen Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Humanized Collagen Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Humanized Collagen Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Humanized Collagen Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Humanized Collagen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Humanized Collagen by Application
  1. 5.1 Recombinant Humanized Collagen Market by Application
  2. 5.1.1 Cosmetics
  3. 5.1.2 Biotechnology
  4. 5.1.3 Medicine
  5. 5.1.4 Other
  6. 5.2 Global Recombinant Humanized Collagen Market Size by Application
  7. 5.2.1 Global Recombinant Humanized Collagen Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Recombinant Humanized Collagen Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Recombinant Humanized Collagen Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Recombinant Humanized Collagen Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Recombinant Humanized Collagen Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Recombinant Humanized Collagen Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Recombinant Humanized Collagen Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Recombinant Humanized Collagen Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Giant Biogene
  2. 6.1.1 Giant Biogene Company Information
  3. 6.1.2 Giant Biogene Business Overview
  4. 6.1.3 Giant Biogene Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Giant Biogene Recombinant Humanized Collagen Product Portfolio
  6. 6.1.5 Giant Biogene Recent Developments
  7. 6.2 Shanxi Jinbo Bio-Pharmaceutical
  8. 6.2.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
  9. 6.2.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
  10. 6.2.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolio
  12. 6.2.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
  13. 6.3 Jiangsu JLand Biotech
  14. 6.3.1 Jiangsu JLand Biotech Company Information
  15. 6.3.2 Jiangsu JLand Biotech Business Overview
  16. 6.3.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolio
  18. 6.3.5 Jiangsu JLand Biotech Recent Developments
  19. 6.4 Jiangsu Chuangjian Medical Technology
  20. 6.4.1 Jiangsu Chuangjian Medical Technology Company Information
  21. 6.4.2 Jiangsu Chuangjian Medical Technology Business Overview
  22. 6.4.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolio
  24. 6.4.5 Jiangsu Chuangjian Medical Technology Recent Developments
  25. 6.5 ProColl
  26. 6.5.1 ProColl Company Information
  27. 6.5.2 ProColl Business Overview
  28. 6.5.3 ProColl Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ProColl Recombinant Humanized Collagen Product Portfolio
  30. 6.5.5 ProColl Recent Developments
  31. 6.6 Evonik
  32. 6.6.1 Evonik Company Information
  33. 6.6.2 Evonik Business Overview
  34. 6.6.3 Evonik Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Evonik Recombinant Humanized Collagen Product Portfolio
  36. 6.6.5 Evonik Recent Developments
  37. 6.7 Creative BioMart
  38. 6.7.1 Creative BioMart Company Information
  39. 6.7.2 Creative BioMart Business Overview
  40. 6.7.3 Creative BioMart Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Creative BioMart Recombinant Humanized Collagen Product Portfolio
  42. 6.7.5 Creative BioMart Recent Developments
  43. 6.8 CollPlant
  44. 6.8.1 CollPlant Company Information
  45. 6.8.2 CollPlant Business Overview
  46. 6.8.3 CollPlant Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CollPlant Recombinant Humanized Collagen Product Portfolio
  48. 6.8.5 CollPlant Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Humanized Collagen Sales by Country
  2. 7.1.1 North America Recombinant Humanized Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Humanized Collagen Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Humanized Collagen Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Humanized Collagen Market Size by Country
  6. 7.2.1 North America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Humanized Collagen Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Humanized Collagen Sales by Country
  2. 8.1.1 Europe Recombinant Humanized Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Humanized Collagen Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Humanized Collagen Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Humanized Collagen Market Size by Country
  6. 8.2.1 Europe Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Humanized Collagen Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Humanized Collagen Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Humanized Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Humanized Collagen Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Humanized Collagen Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Humanized Collagen Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Humanized Collagen Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Humanized Collagen Sales by Country
  2. 10.1.1 South America Recombinant Humanized Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Humanized Collagen Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Humanized Collagen Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Humanized Collagen Market Size by Country
  6. 10.2.1 South America Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Humanized Collagen Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Humanized Collagen Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Humanized Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Humanized Collagen Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Humanized Collagen Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Humanized Collagen Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Humanized Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Humanized Collagen Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Humanized Collagen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Humanized Collagen Value Chain Analysis
  2. 12.1.1 Recombinant Humanized Collagen Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Humanized Collagen Production Mode & Process
  7. 12.2 Recombinant Humanized Collagen Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Humanized Collagen Distributors
  10. 12.2.3 Recombinant Humanized Collagen Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst